Cardiac performance and coenzyme Q10 in thyroid disorders

Endocrinol Jpn. 1984 Dec;31(6):755-61. doi: 10.1507/endocrj1954.31.755.


To investigate the relationship between serum levels of Coenzyme Q10 and cardiac performance in thyroid disorders, we studied the cardiac performance and assessed serum levels of thyroid hormones and Coenzyme Q10 in 20 patients with hyperthyroidism, 5 patients with hypothyroidism and 10 normal subjects. A significant inverse correlation between thyroid hormones and Coenzyme Q10 levels was found by performing partial correlation analysis. Because low serum levels of Coenzyme Q10 were found in thyrotoxic patients and congestive heart failure may occur as a result of severe hyperthyroidism, 120 mg of Coenzyme Q10 was administered daily for one week to 12 hyperthyroid patients and the change in cardiac performance was assessed. Further augmentation of cardiac performance was found in hyperthyroid hearts, which were already augmented, after the administration of Coenzyme Q10. It appears, therefore, that the Coenzyme Q10 dose actually has a therapeutic value for congestive heart failure induced by severe thyrotoxicosis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cardiac Output
  • Coenzymes
  • Female
  • Heart / physiopathology*
  • Humans
  • Hyperthyroidism / drug therapy
  • Hyperthyroidism / physiopathology
  • Middle Aged
  • Systole
  • Thyroid Diseases / blood
  • Thyroid Diseases / enzymology
  • Thyroid Diseases / physiopathology*
  • Thyroid Hormones / blood
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / blood
  • Ubiquinone / metabolism
  • Ubiquinone / therapeutic use


  • Coenzymes
  • Thyroid Hormones
  • Ubiquinone
  • coenzyme Q10